Question of the Day – Monday, June 5, 2023
In a recent case report of a patient treated for what authors believed were symptoms of withdrawal from xylazine, what differences did that patient report between her experience using xylazine as opposed to opioids alone? The patient reported that she would often fall asleep right…
Question of the Day – Friday, June 2, 2023
In a recent case report of a patient hospitalized for treatment of chronic lower extremity wounds thought to be due to xylazine injection, what medications were used to treat symptoms which authors attributed to a withdrawal syndrome from xylazine? Dexmedetomidine, tizanidine, phenobarbital, and clonidine. The…
Question of the Day – Thursday, May 4, 2023
According to the fentanyl study group, a prospective study of patients with suspected opioid overdose in 9 emergency departments in 7 US states, was the presence of xylazine associated with more severe intoxication? No. Outcomes (death, LOS, ICU admits, ED discharge, total dose of naloxone,…
Question of the Day – Wednesday, May 3, 2023
According to data compiled by the fentanyl study group, a prospective study of patients with suspected opioid overdose in 9 emergency departments in 7 US states, were patients with xylazine exposure more or less likely to experience bradycardia? There was no difference in the rates…
Question of the Day – Tuesday, May 2, 2023
What is the difference between a cutting agent and an adulterant? A cutting agent is an inert filler added to a drug to add bulk. An adulterant is a pharmacologically active, non-scheduled drug added to a drug to add bulk or for contributory affect. Examples…